Deep Brain Stimulation Devices Market for Parkinson's Disease Industry Trends, Growth Rate With CAGR Analysis 2020

Deep Brain Stimulation Devices Market: Snapshot

The rise in the global geriatric population, increasing number of patients suffering from Parkinson’s diseases (PD), and growing awareness about neurological movement disorders among patients have triggered the growth of the deep brain stimulation devices market. Globally, neurological disorders are one of the major causes of morality and accounts for approximately 12% of the deaths per annum. Of these, cerebrovascular diseases account for 85% deaths. Parkinson’s disease is the most common neurological disorders after Alzheimer’s disease. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness, and trouble with balance. Drug therapy is the most effective treatment option available to control PD in the initial stages. Though there are several stages of PD, surgical treatment using deep brain stimulation (DBS) devices is more frequently used to control symptoms of disease. DBS devices are an effective, clinically proven, and legally approved advanced treatment option for milk to serve PD.

Obtain the PDF containing Upcoming Market Trends of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1435

The market for deep brain stimulation devices for Parkinson’s diseases is expected to grow at a robust rate of 11% during the forecast period of 2014 to 2020. The opportunity in the market is estimated to reach US$3.2 bn by the end of 2020. The growing burden of PD on healthcare systems, along with the uncertainty of economic conditions in some developed economies such as the U.S. and Europe has forced original equipment manufacturers (OEMs) to develop cost-effective devices for PD treatment.

North America to Maintain Most Prominent Demand for DBS Devices

Geographically, the global market for deep brain stimulation devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America currently serves the maximum demand for DBS devices for Pakistan’s disease, and is expected to maintain its leading position throughout the forecast period from 2014 to 2020, growing at a CAGR of 9.3% in terms of revenue. The region is expected to gain market share of 44.2% by the end of 2020. The key factors attributed to their leading position in the global market are high prevalence and incidence rate of Parkinson’s diseases in the region, aging population, demand for advanced deep brain stimulation devices and presence of high disposable income in the region.

The U.S. was the largest market for DBS devices for the treatment of Parkinson’s disease. According to the centers for Disease Control and Prevention, Pakistan’s disease is the 14th leading cause of death in the U.S. At present, approximately 1 million to 1.2 million people in the U.S. are suffering from Parkinson’s disease. The U.S. is a major R&D and technology center in the world and holds a key share in the healthcare industry with advanced technologies, presence of top companies, and relentless developments. Significant R&D activities are currently being undertaken by the U.S. Government to introduce innovative drugs and devices to help the society in disease management.

Canada is another prominent market for DBS devices for the treatment of Parkinson’s disease. According to the Parkinson’s Society Canada, approximately 100,000 people in Canada suffer from Parkinson’s disease. The disease affects nearly 1% of the population above 65 years of age and 2% of those about 70 years of age. Canada’s healthcare system has implemented a publicly funded insurance program wherein the costs are controlled by both hospitals and doctors. North America was followed by Europe as the widest market for the DBS devices for Parkinson’s diseases. The region is expected to contribute to 33.7% of the demand by the end of the forecast period of 2014–2020. Asia Pacific, though currently accounts for the third most prominent market for deep brain stimulation devices, it is expected to expand at a healthy CAGR of 8% during the forecast period of 2014–2020.

Read the Present Market Status of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html

Some of the key players in global deep brain stimulation devices market are Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc., and St. Jude Medical, Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.